Publication Information

{'id': 'https://openalex.org/W1560455169', 'doi': None, 'title': 'Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.', 'display_name': 'Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.', 'publication_year': 1995, 'publication_date': '1995-05-01', 'ids': {'openalex': 'https://openalex.org/W1560455169', 'mag': '1560455169', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/7786880', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/1188684'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/7786880', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5011410057', 'display_name': 'John C. Pecknold', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I177567560', 'display_name': 'Douglas College', 'ror': 'https://ror.org/03wze7d53', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I177567560']}, {'id': 'https://openalex.org/I2799434747', 'display_name': 'Douglas Mental Health University Institute', 'ror': 'https://ror.org/05dk2r620', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799434747']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'J C Pecknold', 'raw_affiliation_strings': ['Douglas Hospital Research Centre, Verdun, Quebec, Canada.'], 'affiliations': [{'raw_affiliation_string': 'Douglas Hospital Research Centre, Verdun, Quebec, Canada.', 'institution_ids': ['https://openalex.org/I177567560', 'https://openalex.org/I2799434747']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5010851272', 'display_name': 'Lorenz Luthe', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'L Luthe', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5016049623', 'display_name': 'Linda J. Iny', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'L Iny', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5008807483', 'display_name': 'Dhunraj Ramdoyal', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'D Ramdoyal', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.669, 'has_fulltext': False, 'cited_by_count': 15, 'citation_normalized_percentile': {'value': 0.660569, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 81, 'max': 82}, 'biblio': {'volume': '20', 'issue': '3', 'first_page': '193', 'last_page': '8'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10853', 'display_name': 'Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/3205', 'display_name': 'Experimental and Cognitive Psychology'}, 'field': {'id': 'https://openalex.org/fields/32', 'display_name': 'Psychology'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10853', 'display_name': 'Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/3205', 'display_name': 'Experimental and Cognitive Psychology'}, 'field': {'id': 'https://openalex.org/fields/32', 'display_name': 'Psychology'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T13283', 'display_name': 'Mental Health Research Topics', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/3205', 'display_name': 'Experimental and Cognitive Psychology'}, 'field': {'id': 'https://openalex.org/fields/32', 'display_name': 'Psychology'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T11071', 'display_name': 'Treatment of Major Depression', 'score': 0.9993, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/paroxetine', 'display_name': 'Paroxetine', 'score': 0.9048}, {'id': 'https://openalex.org/keywords/alprazolam', 'display_name': 'Alprazolam', 'score': 0.58660746}, {'id': 'https://openalex.org/keywords/agoraphobia', 'display_name': 'Agoraphobia', 'score': 0.5731549}, {'id': 'https://openalex.org/keywords/serotonin-reuptake-inhibitor', 'display_name': 'Serotonin reuptake inhibitor', 'score': 0.49245748}, {'id': 'https://openalex.org/keywords/fluvoxamine', 'display_name': 'Fluvoxamine', 'score': 0.41467825}], 'concepts': [{'id': 'https://openalex.org/C2777828372', 'wikidata': 'https://www.wikidata.org/wiki/Q408471', 'display_name': 'Paroxetine', 'level': 4, 'score': 0.9048}, {'id': 'https://openalex.org/C2776134451', 'wikidata': 'https://www.wikidata.org/wiki/Q422244', 'display_name': 'Fluoxetine', 'level': 4, 'score': 0.8373722}, {'id': 'https://openalex.org/C2777529043', 'wikidata': 'https://www.wikidata.org/wiki/Q741713', 'display_name': 'Panic disorder', 'level': 3, 'score': 0.80161995}, {'id': 'https://openalex.org/C2780712732', 'wikidata': 'https://www.wikidata.org/wiki/Q208450', 'display_name': 'Panic', 'level': 3, 'score': 0.7403632}, {'id': 'https://openalex.org/C2776317618', 'wikidata': 'https://www.wikidata.org/wiki/Q544006', 'display_name': 'Anxiety disorder', 'level': 3, 'score': 0.6717999}, {'id': 'https://openalex.org/C2779145073', 'wikidata': 'https://www.wikidata.org/wiki/Q58396', 'display_name': 'Imipramine', 'level': 3, 'score': 0.6591425}, {'id': 'https://openalex.org/C2777196872', 'wikidata': 'https://www.wikidata.org/wiki/Q319877', 'display_name': 'Alprazolam', 'level': 3, 'score': 0.58660746}, {'id': 'https://openalex.org/C2778678127', 'wikidata': 'https://www.wikidata.org/wiki/Q174589', 'display_name': 'Agoraphobia', 'level': 4, 'score': 0.5731549}, {'id': 'https://openalex.org/C15744967', 'wikidata': 'https://www.wikidata.org/wiki/Q9418', 'display_name': 'Psychology', 'level': 0, 'score': 0.52352977}, {'id': 'https://openalex.org/C2780092697', 'wikidata': 'https://www.wikidata.org/wiki/Q7455053', 'display_name': 'Serotonin reuptake inhibitor', 'level': 4, 'score': 0.49245748}, {'id': 'https://openalex.org/C31487548', 'wikidata': 'https://www.wikidata.org/wiki/Q4859664', 'display_name': 'Reuptake inhibitor', 'level': 4, 'score': 0.475347}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.47007138}, {'id': 'https://openalex.org/C558461103', 'wikidata': 'https://www.wikidata.org/wiki/Q154430', 'display_name': 'Anxiety', 'level': 2, 'score': 0.46510062}, {'id': 'https://openalex.org/C2779910183', 'wikidata': 'https://www.wikidata.org/wiki/Q409236', 'display_name': 'Fluvoxamine', 'level': 5, 'score': 0.41467825}, {'id': 'https://openalex.org/C2775864247', 'wikidata': 'https://www.wikidata.org/wiki/Q167934', 'display_name': 'Serotonin', 'level': 3, 'score': 0.39173836}, {'id': 'https://openalex.org/C2779177272', 'wikidata': 'https://www.wikidata.org/wiki/Q76560', 'display_name': 'Antidepressant', 'level': 3, 'score': 0.38135794}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.3761537}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.32027668}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.052357465}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D005473', 'descriptor_name': 'Fluoxetine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D005473', 'descriptor_name': 'Fluoxetine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D007099', 'descriptor_name': 'Imipramine', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D007099', 'descriptor_name': 'Imipramine', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': True}, {'descriptor_ui': 'D016584', 'descriptor_name': 'Panic Disorder', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D017374', 'descriptor_name': 'Paroxetine', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D017374', 'descriptor_name': 'Paroxetine', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': True}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000379', 'descriptor_name': 'Agoraphobia', 'qualifier_ui': 'Q000150', 'qualifier_name': 'complications', 'is_major_topic': False}, {'descriptor_ui': 'D000379', 'descriptor_name': 'Agoraphobia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005473', 'descriptor_name': 'Fluoxetine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D005473', 'descriptor_name': 'Fluoxetine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007099', 'descriptor_name': 'Imipramine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016584', 'descriptor_name': 'Panic Disorder', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': False}, {'descriptor_ui': 'D016584', 'descriptor_name': 'Panic Disorder', 'qualifier_ui': 'Q000150', 'qualifier_name': 'complications', 'is_major_topic': False}, {'descriptor_ui': 'D016584', 'descriptor_name': 'Panic Disorder', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017374', 'descriptor_name': 'Paroxetine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010352', 'descriptor_name': 'Patient Dropouts', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011446', 'descriptor_name': 'Prospective Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011569', 'descriptor_name': 'Psychiatric Status Rating Scales', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/7786880', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.83}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 27, 'referenced_works': ['https://openalex.org/W1515756878', 'https://openalex.org/W1611542244', 'https://openalex.org/W1963917463', 'https://openalex.org/W1964144827', 'https://openalex.org/W1974290865', 'https://openalex.org/W2000353278', 'https://openalex.org/W2010928495', 'https://openalex.org/W2026744097', 'https://openalex.org/W2037061841', 'https://openalex.org/W2042167308', 'https://openalex.org/W2045973153', 'https://openalex.org/W2051918534', 'https://openalex.org/W2059626910', 'https://openalex.org/W2062186695', 'https://openalex.org/W2068629053', 'https://openalex.org/W2070754474', 'https://openalex.org/W2073424974', 'https://openalex.org/W2079507733', 'https://openalex.org/W2080087031', 'https://openalex.org/W2081526164', 'https://openalex.org/W2083242420', 'https://openalex.org/W2101949700', 'https://openalex.org/W2114613490', 'https://openalex.org/W2406451703', 'https://openalex.org/W2409428117', 'https://openalex.org/W2411224290', 'https://openalex.org/W2430047238'], 'related_works': ['https://openalex.org/W2479427747', 'https://openalex.org/W2330704565', 'https://openalex.org/W2249026036', 'https://openalex.org/W2123243221', 'https://openalex.org/W2073424974', 'https://openalex.org/W2056310730', 'https://openalex.org/W2030441588', 'https://openalex.org/W1990519761', 'https://openalex.org/W1988030263', 'https://openalex.org/W1560455169'], 'abstract_inverted_index': {'Serotonergic': [0], 'implication': [1], 'in': [2, 15, 79, 150, 174, 185], 'panic': [3, 73, 124, 143, 156, 172], 'disorder': [4, 74, 173], 'has': [5, 23], 'been': [6, 24], 'demonstrated': [7], 'by': [8, 126, 191], 'the': [9, 93, 96, 102, 120, 130, 139, 186, 192, 195], 'efficacy': [10], 'of': [11, 45, 72, 85, 92, 101, 106, 109, 115, 119, 132, 135, 138, 188, 194], 'serotonin': [12], 'reuptake': [13, 21], 'blockers': [14], 'treatment.': [16], 'Fluoxetine,': [17], 'a': [18, 80, 113, 147, 181], 'potent': [19], '5-HT': [20], 'blocker,': [22], 'suggested': [25], 'to': [26, 51, 183], 'have': [27], 'anti-panic': [28], 'efficacy.': [29, 116], 'This': [30], 'open': [31], 'study': [32], 'examines': [33], '30': [34], 'patients': [35, 68, 87, 94, 103, 121, 140, 170], '(eight': [36], 'males': [37], 'and': [38, 99, 152, 155, 161], '22': [39], 'females)': [40], 'with': [41, 59, 75, 171, 176], 'an': [42], 'average': [43], 'age': [44], '36.9': [46], 'years,': [47], 'ranging': [48], 'from': [49], '18': [50], '62,': [52], 'who': [53, 88], 'were': [54], 'treated': [55], 'for': [56, 169], 'eight': [57, 133], 'weeks': [58, 134], 'fluoxetine': [60], '(mean': [61], 'dose': [62], '20': [63], 'mg': [64], 'per': [65], 'day).': [66], 'All': [67], 'fulfilled': [69], 'DSM-III-R': [70], 'criteria': [71], 'agoraphobia': [76], 'as': [77], 'determined': [78], 'SCID': [81], 'interview': [82], 'schedule.': [83], 'Out': [84], '28': [86], 'started': [89], 'medication,': [90], '64%': [91], 'completed': [95], 'clinical': [97], 'trial': [98], '36%': [100], 'dropped': [104], 'out': [105], 'treatment': [107], 'because': [108], 'increased': [110], 'anxiety': [111, 151], 'or': [112], 'lack': [114], 'Thirty-two': [117], 'percent': [118], 'had': [122, 141], 'zero': [123, 142], 'attacks': [125], 'week': [127], '3.': [128], 'By': [129], 'end': [131, 193], 'treatment,': [136], '48%': [137], 'attacks.': [144, 157], 'There': [145], 'was': [146], 'significant': [148], 'reduction': [149], 'phobic': [153], 'avoidance': [154], 'Tritiated': [158], 'platelet': [159], 'imipramine': [160], 'paroxetine': [162], 'bindings': [163], 'revealed': [164], 'significantly': [165], 'lower': [166], 'maximal': [167], 'binding': [168], 'comparison': [175], 'controls.': [177], 'Paroxetine': [178], 'Bmax': [179], 'showed': [180], 'trend': [182], 'increase': [184], 'direction': [187], 'control': [189], 'values': [190], 'trial.': [196]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1560455169', 'counts_by_year': [{'year': 2018, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-16T05:46:07.989179', 'created_date': '2016-06-24'}